Drug intelligence / Profile preview

felodipine + hydrochlorothiazide

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral
01

Overview

Felodipine + hydrochlorothiazide is a combination of two antihypertensive agents used to treat high blood pressure. Felodipine is a long-acting dihydropyridine calcium channel blocker that lowers blood pressure by relaxing vascular smooth muscle through inhibition of voltage-gated L-type calcium channels, leading to vasodilation and reduced arterial contractility[4][5]. Hydrochlorothiazide is a thiazide diuretic that reduces blood pressure by promoting renal excretion of sodium and water, thereby decreasing plasma volume and peripheral vascular resistance[2][3]. The combination targets both vascular tone and fluid balance for additive antihypertensive effects. This therapy is primarily indicated for the management of hypertension in adults.

02

Targets

LTCC (Voltage-gated calcium channel (L-type))CaM (Calmodulin)TNC (Tenascin-C fibronectin type III domains)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)CaV3 (Caveolin-3)

Beyond the preview

Go deeper on felodipine + hydrochlorothiazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on felodipine + hydrochlorothiazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call